Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-074940
Filing Date
2016-01-08
Accepted
2016-01-08 17:31:16
Documents
1
Period of Report
2016-01-06

Document Format Files

Seq Description Document Type Size
1 form476492_20160108053037-.html 4  
1 form476492_20160108053037-.xml 4 3134
  Complete submission text file 0001144204-16-074940.txt   4476
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
GUETH ANTON (Reporting) CIK: 0001274940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 161334474